Condition: Intermediate AMD · Sponsor: Oculox Technologies SA
The proposed clinical investigation wants primary to validate the safety of the innovative light therapy approach and in second priority provide insight and confirmations on therapeutic effect. By combining two clinically standard laser-light treatment, both exhibiting a solid-safe profile: the photothermal and the photobiological techniques; the investigational device (reSEES) wants to explore a completely new therapeutic approach by synergically take advantage of the inherent and already observed clinical performances of the two independent techniques.
This description comes directly from the study's public registry record.
Mario Romano, Prof. · +39 02 8224 2555 · mario.romano.md@gmail.com
Maria Belotti, MD · +39 02 8224 2555 · maria.belotti@gavazzeni.it
Always discuss trial participation with your own doctor first.
| Humanitas Castelli | Bergamo, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06557369